OSUR (OraSure Technologies Inc)
Insider Trading Activity
Every open-market purchase and sale reported by OSUR officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-05 | John P. Kenny | Director | A | — | — |
| 2026-06-05 | Robert W. McMahon | Director | A | — | — |
| 2026-06-05 | John D. Bertrand | Director | A | — | — |
| 2026-06-05 | Nancy J Gagliano | Director | A | — | — |
| 2026-06-05 | Lelio Marmora | Director | A | — | — |
| 2026-06-05 | Steven Kyle Boyd | Director | A | — | — |
| 2026-05-14 | Steven Kyle Boyd | Director | Buy | — | — |
| 2026-05-14 | John D. Bertrand | Director | A | — | — |
| 2026-05-14 | Lelio Marmora | Director | F | — | — |
| 2026-05-14 | Nancy J Gagliano | Director | F | — | — |
| 2026-05-14 | Robert W. McMahon | Director | F | — | — |
| 2026-03-30 | Steven Kyle Boyd | Director | MIXED | — | — |
| 2026-03-23 | Kenneth J McGrath | Chief Financial Officer | Buy | — | — |
| 2026-03-23 | MANNER CARRIE EGLINTON | President & CEO | Buy | — | — |
| 2026-03-19 | Michele Marie Anthony | SVP Finance & CAO | MIXED | — | — |
| 2026-03-16 | MANNER CARRIE EGLINTON | President & CEO | Buy | — | — |
| 2026-03-16 | Kenneth J McGrath | Chief Financial Officer | Buy | — | — |
| 2026-03-03 | Kenneth J McGrath | Chief Financial Officer | MIXED | — | — |
| 2026-03-03 | MANNER CARRIE EGLINTON | President & CEO | MIXED | — | — |
| 2025-12-19 | John P. Kenny | Director | A | — | — |
| 2025-12-02 | Nancy J Gagliano | Director | Buy | — | — |
| 2025-12-02 | Steven Kyle Boyd | Director | A | — | — |
| 2025-09-26 | John P. Kenny | Director | A | — | — |
| 2025-08-11 | Kenneth J McGrath | Chief Financial Officer | F | — | — |
| 2025-08-04 | Robert W. McMahon | Director | F | — | — |
| 2025-06-25 | John P. Kenny | Director | A | — | — |
| 2025-06-05 | MANNER CARRIE EGLINTON | President & CEO | MIXED | — | — |
| 2025-05-15 | John P. Kenny | Director | A | — | — |
| 2025-05-15 | David Shulkin | Director | MIXED | — | — |
| 2025-05-15 | Robert W. McMahon | Director | MIXED | — | — |
| 2025-05-15 | Lelio Marmora | Director | MIXED | — | — |
| 2025-05-15 | Nancy J Gagliano | Director | MIXED | — | — |
| 2025-05-15 | Mara G. Aspinall | Director | MIXED | — | — |
| 2025-03-27 | John P. Kenny | Director | F | — | — |
| 2025-03-04 | Michele Marie Anthony | SVP Finance & CAO | MIXED | — | — |
| 2025-03-04 | MANNER CARRIE EGLINTON | President & CEO | MIXED | — | — |
| 2025-03-04 | Kenneth J McGrath | Chief Financial Officer | MIXED | — | — |
| 2025-03-04 | Kathleen Gallagher Weber | Chief Product Officer | MIXED | — | — |
| 2025-03-03 | Nancy J Gagliano | Director | Buy | — | — |
| 2025-03-03 | MANNER CARRIE EGLINTON | President & CEO | Buy | — | — |
| 2025-02-27 | Kenneth J McGrath | Chief Financial Officer | Buy | — | — |
| 2025-02-27 | Lelio Marmora | Director | Buy | — | — |
| 2025-02-27 | MANNER CARRIE EGLINTON | President & CEO | Buy | — | — |
| 2025-02-27 | John P. Kenny | Director | Buy | — | — |
| 2025-02-04 | Michele Marie Anthony | SVP Finance & CAO | F | — | — |
| 2025-02-04 | Kathleen Gallagher Weber | Chief Product Officer | MIXED | — | — |
| 2025-01-07 | Michele Marie Anthony | SVP Finance & CAO | F | — | — |
| 2025-01-07 | Kathleen Gallagher Weber | Chief Product Officer | F | — | — |
| 2024-09-10 | John P. Kenny | Director | A | — | — |
| 2024-08-09 | Kenneth J McGrath | Chief Financial Officer | F | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | President & CEO | 2,190,874 | — |
| — | President & CEO | 670,231 | — |
| — | Chief Financial Officer | 589,562 | — |
| — | President and CEO | 497,681 | — |
| — | Chief Product Officer | 399,518 | — |
| — | President and CEO | 349,793 | — |
| — | COO & CFO | 274,747 | — |
| — | Director | 209,714 | — |
| — | Director | 188,032 | — |
| — | Director | 185,055 | — |
| — | EVP & BU Lead - Infectious | 179,874 | — |
| — | Managing Director, Europe | 176,637 | — |
| — | Director | 159,568 | — |
| — | SVP Finance & CAO | 157,685 | — |
| — | Director | 154,061 | — |
| — | Director | 148,460 | — |
| — | Exec. VP & GM Cryo. Sys. Div. | 147,874 | — |
| — | SVP General Counsel & CCO | 131,811 | — |
| — | President of Diagnostics | 123,479 | — |
| — | Director | 123,137 | — |
| — | Chief Financial Officer | 120,705 | — |
| — | Director | 111,823 | — |
| — | Director | 107,741 | — |
| — | CFO | 107,479 | — |
| — | Director | 104,782 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the OSUR quote page; the site-wide leaderboard is on the insider transactions hub.